- Home
- KG vs QTRX Comparison
KG vs QTRX Comparison
Compare KG & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KG
- QTRX
- Stock Information
- Founded
- KG N/A
- QTRX 2007
- Country
- KG Bermuda
- QTRX United States
- Employees
- KG N/A
- QTRX N/A
- Industry
- KG Property-Casualty Insurers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- KG Finance
- QTRX Industrials
- Exchange
- KG Nasdaq
- QTRX Nasdaq
- Market Cap
- KG 266.5M
- QTRX 261.7M
- IPO Year
- KG N/A
- QTRX 2017
- Fundamental
- Price
- KG $27.20
- QTRX $4.81
- Analyst Decision
- KG
- QTRX Hold
- Analyst Count
- KG 0
- QTRX 4
- Target Price
- KG N/A
- QTRX $11.75
- AVG Volume (30 Days)
- KG 16.6K
- QTRX 687.8K
- Earning Date
- KG 08-15-2025
- QTRX 11-11-2025
- Dividend Yield
- KG N/A
- QTRX N/A
- EPS Growth
- KG N/A
- QTRX N/A
- EPS
- KG N/A
- QTRX N/A
- Revenue
- KG $5,462,137.00
- QTRX $125,784,000.00
- Revenue This Year
- KG N/A
- QTRX $2.23
- Revenue Next Year
- KG N/A
- QTRX $36.01
- P/E Ratio
- KG $631.87
- QTRX N/A
- Revenue Growth
- KG 250.18
- QTRX N/A
- 52 Week Low
- KG $20.51
- QTRX $4.05
- 52 Week High
- KG $36.80
- QTRX $15.86
- Technical
- Relative Strength Index (RSI)
- KG 54.26
- QTRX 50.31
- Support Level
- KG $25.04
- QTRX $4.25
- Resistance Level
- KG $27.42
- QTRX $4.60
- Average True Range (ATR)
- KG 1.46
- QTRX 0.22
- MACD
- KG -0.10
- QTRX 0.06
- Stochastic Oscillator
- KG 57.59
- QTRX 84.21
About KG Kestrel Group Ltd.
Kestrel Group Ltd is specializes in providing fronting services to insurance program managers, MGAs, reinsurers, and reinsurance brokers. The Group facilitates insurance transactions utilizing its management contracts with four insurance carriers. Its line business includes casualty, workers' compensation, catastrophe-exposed property, and non-catastrophe-exposed property, with diverse risk durations, sizes, and product types.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.